quitting tirzepatide Stopping Leads to Rebound in Weight, Cardiometabolic Risk When to Stop Tirzepatide: A

Reach out to our team

Some practitioners believe glycine helps preserve lean muscle mass during rapid weight loss, though clinical evidence specifically supporting this benefit in GLP-1 patients remains limited

Retatrutide dose levels tested in clinical trials The Phase 2 trial published in the New England Journal of Medicine tested four dose tiers against placebo over 48 weeks

Patients must understand that discontinuation typically results in weight regain and reversal of metabolic improvements, emphasizing the chronic nature of obesity management

This makes it an excellent tool for managing weight and supporting metabolic health